Atlanta Pitch Round proves that the Southeast is rich in medtech innovation talent
We placed a bow on our six-stop tour of the Southeast at PitchRounds Road Show on March 21st in Atlanta Georgia, the site of our 2017 flagship conference. To a crowd of more than 50 medtech professionals at Roam Innovative Workspace, five startups pitched their medical technologies demonstrating the strength of the Southeast’s medtech community. All five were highly impressive and we know that we experienced only a small fraction of Atlanta’s medical device innovation talent.
Pitching competitors CorAmi, Cathaid, Dyop Vision Associates, Hygeia Health, and PreTel Health each took a shot at a chance to take the stage at SEMDA’s 2017 flagship annual conference in Atlanta- where innovators gain access to the entirety of the SE’s medtech community.
Congratulations PreTel Health- we will see you in late April!
PreTel is a clinical monitoring device and decision support solution for all stages of pregnancy. Mike Finch, Co-founder and CEO of PreTel talked about the company’s fetal heart rate monitoring technology differentiates true from false labor. False labor frequently leads to unnecessary invasive monitoring, C-section deliveries and expensive neonatal intensive care nursery stays.
Because there is not an effective tool on the market that can detect and recognize patterns in synchronized contractions, poorly informed decisions made regarding labor can be costly and accompanied by costly outcomes.
The device is an area sensor that covers seven sections of the abdomen in order to track contractions, providing a more accurate picture of uterine activity. The device was developed by Dr. Roger Young, MD, Co-founder and CMO of PreTel who holds more than a decade of experience in obstetrics and gynecological institutional research. The PreTel sensors interface with existing standard fetal monitors or internet hardware and also works for bluetooth and the cloud for remote monitoring.
There are 4 million births per year in the United States. There is currently $38 billion spent on NICU care from preterm delivery, and $5 billion could be saved by reducing C-sections from the current 33% to recommended 15% of cases. The PreTel team is entering directly into a $900 million market and their device could help save the industry billions in cost.
PreTel is currently pursuing an FDA Class III 510K clearance and conducting clinical trials in three sites. We are excited to have you on stage during the conference in less than one month, PreTel!
We want to thank our Atlanta pitch round sponsors Mercer University School of Business, GCMI and Georgia Bio, and the following RoadShow regional program partners as well: BakerHostetler, Butler Snow, GCMI, Johnson & Johnson Innovation, Medmarc, and Write2Market.
“SEMDA serves as the central connecting hub for the Southeast medtech community. We have met new companies at SEMDA that are now MMA clients. Through our involvement with SEMDA, we have been able to connect our clients with investors, suppliers, and specialists to help their business succeed.” – Courtney Warren, Consultant, Marsh & McLennan Agency, LLC
Access the entirety of the Southeast medtech ecosystem including each of the PitchRounds winners from Birmingham, Orlando, Charleston, Memphis, Raleigh, and Atlanta by registering for SEMDA 2017 today.
Paul Gianneschi, Managing Principal and Founder of Hatch Medical, on the value that SEMDA holds.